Table 3 Adverse events during the follow-up.
Clinical adverse events | [no. (%)] |
|---|---|
Nausea or vomiting and/or abdominal discomfort | 38 (7.4) |
Diarrhea | 9 (1.7) |
Lypodystrophy | 6 (1.1) |
Rash | 4 (0.8) |
Fatigue | 6 (1.1) |
Depression | 4 (0.8) |
Dizziness | 4 (0.8) |
Headache | 1 (0.02) |
Hepatic encephalopathy | 1 (0.02) |
Insomnia | 1 (0.02) |
Seizure | 1 (0.02) |
Laboratory adverse events | |
AST or ALT increase (grade 2-4) | 62 (12.0) |
SCr elevation (grade 1) | 5 (1.2) |
Anemia and thrombocytopenia | 1 (0.02) |